A selected active pharmaceutical ingredient must be incorporated into a cargo carrier in a particularmanner so that it achieves its goal. An amalgamation of active pharmaceutical ingredients (APIs) should be conducted in such amanner that it is simple, professional, andmore beneficial. Lipids/polymers that are known to be used in nanocarriers for APIs can be transformed into a vesicular formulation, which offers elegant solutions tomany problems. Phospholipidswith other ingredients, such as ethanol andwater, formsuitable vesicular carriers formany drugs, overcomingmany problems related to poor bioavailability, poor solubility, etc. Ultraflexible liposomes are novel carriers and new frontiers of drug delivery for transdermal systems. Auxiliary advances in vesicular carrier research have been made, enabling polymercoated ethanolic liposomes to avoid detection by the body’s immune system—specifically, the cells of the reticuloendothelial system. Ultraflexible liposomes act as a cargo system and a nanotherapeutic approach for the transport of therapeutic drugs and bioactive agents. Various applications of liposome derivatives in different diseases are emphasized in this review.
A selected active pharmaceutical ingredient must be incorporated into a cargo carrier in a particularmanner so that it achieves its goal. An amalgamation of active pharmaceutical ingredients (APIs) should be conducted in such amanner that it is simple, professional, andmore beneficial. Lipids/poly...
مادة فرعية
